CATABASIS PHARMACEUTICALS IN

CUSIP: 14875P206 Class: COM NEW

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 80,717 Value ($000) $170 Avg Close — Range —
Q1 2021
Shares 34,992 Value ($000) $101 Avg Close — Range —
Q4 2020
Shares 15,998 Value ($000) $34 Avg Close — Range —
Q3 2020
Shares 30,662 Value ($000) $190 Avg Close — Range —
Q2 2020
Shares 42,043 Value ($000) $270 Avg Close — Range —